QUANTUM GENOMICS Stock Euronext Paris
Equities
FR0011648971
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 4.5M 4.86M 6.64M |
---|---|---|---|---|---|
Net income 2024 * | -3M -3.24M -4.43M | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | 8.7M 9.39M 12.84M | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.44
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.23% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | - | |
Lionel Ségard
FOU | Founder | 56 | 05-12-22 |
Benoît Gueugnon
DFI | Director of Finance/CFO | - | 18-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lionel Ségard
FOU | Founder | 56 | 05-12-22 |
François Pelen
BRD | Director/Board Member | 67 | - |
Chief Executive Officer | 63 | - |
1st Jan change | Capi. | |
---|---|---|
+26.37% | 48.16B | |
-1.01% | 41.73B | |
+44.93% | 41.03B | |
-5.31% | 28.77B | |
+9.34% | 25.59B | |
-21.69% | 18.96B | |
+6.23% | 12.92B | |
+26.99% | 12.03B | |
-3.38% | 11.77B |